908 Devices (MASS) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- -$0.06
- Estimate
- -$0.10
- Surprise
- +46.5%
- Revenue (period 2026-09-30)
- $18.9M
- Score today
- 5.8/10
Revenue source: xbrl.
How the report landed
908 Devices (MASS) reported a narrower loss than forecast — adjusted EPS of -$0.06 against the -$0.10 estimate (a 46.5% beat on a still-unprofitable quarter).
Coverage in the report window
- Stifel Maintains Buy on 908 Devices, Raises Price Target to $14 — benzinga, 2026-11-11
- 908 Devices Q3 2026 Earnings Call Transcript — benzinga, 2026-11-10
- 908 Devices Reports Third Quarter 2026 Financial Results — fiscal.ai, 2026-11-10
Where TrendMatrix's rating stands now
TrendMatrix currently rates MASS Hold at 5.8/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate; this quarter's +46.5% surprise compares with a +78.5% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (3/4)
What argues against it
- Concentration risk — Product: handheld products
- Concentration risk — Supplier: single source suppliers and subassembly manufacturers
- V7 low-quality RISK_OFF penalty: -0.5 (Q=4.2)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $9.98
- Price target
- $11.37
- Stop
- $9.53
- Upside to target
- +13.9%
- Reward-to-risk
- 0.9:1
Risk check: trading volume is running 2.3× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-11-11 — shown for context, not personalized investment advice.
MASS at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $412.7M
- P/E (fwd)
- -32.5
- 52-week range
- $5.03–$13.35
- Off 52-week high
- 25.2%
- RSI (14)
- 40
- Volume vs avg
- 2.31×
- Score today
- 5.8/10